BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19289781)

  • 21. [Myocardial ischaemia as a result of treatment with capecitabine].
    van Halteren HK; Liem AH; Planting AS
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
    Saadati H; Saif MW
    JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    Callen JP
    JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
    [No Abstract]   [Full Text] [Related]  

  • 25. Dermatomyositis associated with capecitabine in the setting of malignancy.
    Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
    J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
    [No Abstract]   [Full Text] [Related]  

  • 26. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
    Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
    An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
    [No Abstract]   [Full Text] [Related]  

  • 27. Capecitabine induced colitis.
    Maggo G; Grover SC; Grin A
    Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
    Li Z; Jiang N; Xu Y
    Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute coronary syndrome during oral capecitabine monotherapy].
    Martí V; Monell J; Seixo F; Falces C
    Rev Esp Cardiol; 2008 May; 61(5):548-9. PubMed ID: 18462663
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
    Rashidi A; Man L; Howard JR; Atienza D; Fisher SI
    Leuk Lymphoma; 2014 Mar; 55(3):683-4. PubMed ID: 23837492
    [No Abstract]   [Full Text] [Related]  

  • 32. Onycholysis associated with capecitabine in patients with breast cancer.
    Hogeling M; Howard J; Kanigsberg N; Finkelstein H
    J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Increased INR from concomitant use of acenocoumarol and capecitabine].
    Tomlow B; Voll ML; Smorenburg CH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4793. PubMed ID: 22759711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
    Bar-Sela G; Haim N
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs associated with capecitabine or 5-fluorouracil monotherapy after surgical resection in patients with colorectal cancer.
    Chu E; Shi N; Wei W; Bendell JC; Cartwright T
    Oncology; 2009; 77(3-4):244-53. PubMed ID: 19738390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy traces on hands and feet in a patient with colon cancer].
    Stiefelhagen P
    MMW Fortschr Med; 2012 Jun; O 154 Suppl 2():9. PubMed ID: 22916416
    [No Abstract]   [Full Text] [Related]  

  • 37. Capecitabine-induced cerebellar toxicity.
    Renouf D; Gill S
    Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging role of capecitabine in gastric cancer.
    Comella P; Franco L; Casaretti R; de Portu S; Menditto E
    Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stevens-Johnson syndrome after treatment with capecitabine.
    Sendur MA; Kilickap S
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):202-3. PubMed ID: 18160271
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor lysis syndrome following a single dose of capecitabine.
    Kurt M; Eren OO; Engin H; Güler N
    Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.